Santa Cruz Biotechnology delivers a wide array of ZNF174 monoclonal antibodies for research focused on understanding ZNF174 protein functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ZNF174, a member of the zinc finger protein family, plays a critical role in gene regulation and cellular processes. ZNF174 is involved in transcriptional repression and has been implicated in various biological functions, including development and differentiation. Research has shown that ZNF174 may influence multiple cellular pathways and molecular mechanisms. Understanding ZNF174's function is essential for elucidating its potential impact on diseases and therapeutic targets. Investigating ZNF174's role in development and differentiation can provide valuable insights into normal cellular processes and disease states. Current research continues to uncover new aspects of ZNF174's biological significance and potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of ZNF174 and its impact on human health.